Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1

Article metrics

Abstract

MAMMALIAN cell-cycle control by antimitogenic signals involves p21Cip1/WAF1(refs 1–4), p27Kip1 (refs 5,6) andp57Kip2(refs 7,8) a family of proteins that bind to and inhibit cyclin-dependent kinases (CDKs) required for initiation of S phase. The protein p21 also binds to the DNA polymerase δ processivity factor, proliferating-cell nuclear antigen (PCNA), and inhibits in vitro PCNA-dependent DNA replication9,10. The CDK and PCNA inhibitory activities of p21 are shown here to be functionally independent and to reside in separate protein domains. The PCNA binding and inhibitory activities, which are not observed with p27 or p57, reside in the C-terminal domain of p21, whereas the CDK inhibitory activity resides in the conserved N-terminal domains of these proteins. When separately overexpressed in mammalian cells, the CDK and PCNA inhibitory domains prevent DNA replication, demonstrating a dual function of p21 as a cell-cycle inhibitor in vivo.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    El-Deiry, W. S. et al. Cell 75, 817–825 (1993).

  2. 2

    Gu, Y., Turck, C. W. & Morgan, D. O. Nature 366, 707–710 (1993).

  3. 3

    Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K. & Elledge, S. J. Cell 75, 805–816 (1993).

  4. 4

    Xiong, Y. et al. Nature 366, 701–704 (1993).

  5. 5

    Polyak, K. et al. Cell 78, 59–66 (1994).

  6. 6

    Toyoshima, H. & Hunter, T. Cell 78, 67–74 (1994).

  7. 7

    Lee, M.-H., Reynisdóttir, I. & Massagué, J. Genes Dev. 9, 639–649 (1995).

  8. 8

    Matsuoka, S. et al. Genes Dev. 9, 650–662 (1995).

  9. 9

    Waga, S., Hannon, G. J., Beach, D. & Stillman, B. Nature 369, 574–578 (1994).

  10. 10

    Flores-Rozas, H. et al. Proc. natn. Acad. Sci. U.S.A. 91, 8655–8659 (1994).

  11. 11

    Attisano, L. et al. Cell 75, 671–680 (1993).

  12. 12

    Kalderon, D., Roberts, B. L., Richardson, W. D. & Smith, A. E. Cell 39, 499–509 (1984).

  13. 13

    Matsushime, H. et al. Cell 71, 323–334 (1992).

  14. 14

    Kelman, Z., Naktinis, V. & O'Donnell, M. Meth. Enzym. (in the press).

  15. 15

    Desai, D., Gu, Y. & Morgan, D. O. Molec. Biol. Cell 3, 571–582 (1992).

  16. 16

    Kato, J., Matsuoka, M., Potyak, K., Massagué, J. & Sherr, C. J. Cell 79, 487–496 (1994).

  17. 17

    Laiho, M., DeCaprio, J. A., Ludlow, J. W., Livingston, D. M. & Massagué, J. Cell 62, 175–185 (1990).

  18. 18

    Warbrick, E., Lane, D. P., Glover, D. M. & Cox, L. S. Curr. Biol. 5, 275–282 (1995).

  19. 19

    Chen, J., Jackson, P. K., Kirschner, M. W. & Dutta, A. Nature 374, 386–388 (1995).

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Luo, Y., Hurwitz, J. & Massagué, J. Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1. Nature 375, 159–161 (1995) doi:10.1038/375159a0

Download citation

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.